Who
ARCH Venture Fund IX, L.P.
10% owner
Company insider
Files Form 4 as: 10% owner, Boundless Bio; 10% owner, Vir Biotechnology; 10% owner, Lyell Immunopharma; 10% owner, Beam Therapeutics.
In numbers
- Trades disclosed
- 38
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $40K
- Companies
- 4
- Companies where not an officer
- 4
- First trade
- 31 Mar 2021
- Last trade
- 1 Jul 2026
- Last filed
- 6 Jul 2026
Companies traded
Activity over time
1 Jun – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jul 2026filed 6 Jul 2026 | BOLD Boundless BioBiotechnology | SEC FORM 4 Code M | $16K16,000 at $1.03 | filing |
| 1 Jul 2026filed 6 Jul 2026 | BOLD Boundless BioBiotechnology | SEC FORM 4 Sold | $40K16,000 at $2.49 | filing |
| 1 Jul 2026filed 6 Jul 2026 | BOLD Boundless Biooption or derivative · Biotechnology | SEC FORM 4 Code M | —16,000 at $0.00 | filing |
| 25 Aug 2022filed 26 Aug 2022 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Code J | —217,781 at $0.00 | filing |
| 25 Aug 2022filed 26 Aug 2022 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Code J | —282,219 at $0.00 | filing |
| 25 Aug 2022filed 26 Aug 2022 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Code J | —13,076 at $0.00 | filing |
| 25 Aug 2022filed 26 Aug 2022 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Code J | —1,475 at $0.00 | filing |
| 25 Aug 2022filed 26 Aug 2022 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Code J | —2,952 at $0.00 | filing |
| 24 Aug 2022filed 26 Aug 2022 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Code J | —217,781 at $0.00 | filing |
| 24 Aug 2022filed 26 Aug 2022 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Code J | —282,219 at $0.00 | filing |
| 24 Aug 2022filed 26 Aug 2022 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Code J | —13,076 at $0.00 | filing |
| 24 Aug 2022filed 26 Aug 2022 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Code J | —1,475 at $0.00 | filing |
| 24 Aug 2022filed 26 Aug 2022 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Code J | —2,952 at $0.00 | filing |
| 16 Aug 2022filed 16 Aug 2022 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Code J | —217,781 at $0.00 | filing |
| 16 Aug 2022filed 16 Aug 2022 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Code J | —282,219 at $0.00 | filing |
| 16 Aug 2022filed 16 Aug 2022 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Code J | —13,076 at $0.00 | filing |
| 16 Aug 2022filed 16 Aug 2022 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Code J | —1,475 at $0.00 | filing |
| 16 Aug 2022filed 16 Aug 2022 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Code J | —2,952 at $0.00 | filing |
| 15 Aug 2022filed 16 Aug 2022 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Code J | —217,781 at $0.00 | filing |
| 15 Aug 2022filed 16 Aug 2022 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Code J | —282,219 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.